TD Waterhouse Canada’s ESSA Pharma EPIX Stock Holding History

TD Waterhouse Canada’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-900	Closed	-$185	–	2084
2025 Q3	$185	Hold	900	–	–	﹤0.01%	1968
2025 Q2	$1.53K	Hold	900	–	–	﹤0.01%	1756
2025 Q1	$1.4K	Hold	900	–	–	﹤0.01%	1715
2024 Q4	$1.62K	Hold	900	–	–	﹤0.01%	1732
2024 Q3	$5.22K	Hold	900	–	–	﹤0.01%	1487
2024 Q2	$4.51K	Hold	900	–	–	﹤0.01%	1513
2024 Q1	$7.29K	Hold	900	–	–	﹤0.01%	1435
2023 Q4	$5.54K	Hold	900	–	–	﹤0.01%	1360
2023 Q3	$2.64K	Hold	900	–	–	﹤0.01%	1464
2023 Q2	$2.41K	Hold	900	–	–	﹤0.01%	1516
2023 Q1	$2.63K	Hold	900	–	–	﹤0.01%	1480
2022 Q4	$2.28K	Hold	900	–	–	﹤0.01%	1471
2022 Q3	$1.59K	Hold	900	–	–	﹤0.01%	1529
2022 Q2	$2.53K	Hold	900	–	–	﹤0.01%	1513
2022 Q1	$5.93K	Hold	900	–	–	﹤0.01%	1422
2021 Q4	$12.5K	Buy	+900	New	+$10K	﹤0.01%	1299

TD Waterhouse Canada's EPIX Position: Q4 2025 in Review

TD Waterhouse Canada sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 900 shares — an estimated $185 sold.

TD Waterhouse Canada first reported a position in EPIX in Q4 2021 and held it in 16 quarters. The position peaked at $12.5K in Q4 2021. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.

TD Waterhouse Canada reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
TD Waterhouse Canada sold 900 ESSA Pharma shares in Q4 2025, an estimated $185.
TD Waterhouse Canada first reported a position in ESSA Pharma in Q4 2021 and held it in 16 quarters.
TD Waterhouse Canada's ESSA Pharma position peaked at $12.5K in Q4 2021.
0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.

Based on TD Waterhouse Canada's 13F filing for Q4 2025, filed 27 Jan 2026.